Abstract
The posttraumatic stress disorder (PTSD) Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; PCL-5) was designed and validated to track symptoms over the past month (PCL-5-M), yet an untested ad hoc weekly version (PCL-5-W) is commonly used to track changes during treatment. We used archival data of clinical trials for the treatment of PTSD in veterans to assess the construct validity of PCL-5-W. Both PCL-5-M and PCL-5-W were found to have configural measurement invariance across four consecutive administrations. The results also indicated at least partial metric and scalar invariance for each version. The reliability estimates of PCL-5-M and PCL-5-W at each time point were equivalent. However, we found a discrepancy with regard to concurrent validity; correlations with the nine-item Patient Health Questionnaire may be meaningfully different between PCL-5-M and PCL-5-W. Nevertheless, overall, the results suggest that PCL-5-W can be validly used to assess PTSD symptoms over time, but factor scores may need to be tracked alongside total scores to address validity concerns.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
